3
Announcements
Trials
Browse
Landscape
Status
Recruiting
404
Active not recruiting
236
Completed
90
Not yet recruiting
84
Terminated
41
Suspended
8
Enrolling by invitation
4
Available
4
No longer available
2
Temporarily not available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
telisotuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Temporarily not available
×
Carcinoma, Non-Small-Cell Lung
×
90 days
×
Clear all
NCT04830202
2026-05-13
Expanded Access to Telisotuzumab Vedotin
AbbVie
Temporarily not available